Nystatin Dosing for Adults
For mild oropharyngeal candidiasis (thrush) in adults, use nystatin suspension 100,000 U/mL at 4-6 mL four times daily OR nystatin pastilles 200,000 U, taking 1-2 pastilles four times daily, for 7-14 days 1.
Dosing by Indication
Oropharyngeal Candidiasis (Thrush)
Mild Disease:
- Nystatin suspension (100,000 U/mL): 4-6 mL swish and swallow four times daily for 7-14 days 1
- Nystatin pastilles (200,000 U each): 1-2 pastilles four times daily for 7-14 days 1
These are considered alternative agents to first-line clotrimazole troches or miconazole buccal tablets, but represent strong recommendations with moderate-quality evidence from the 2016 IDSA guidelines 1.
Important Clinical Considerations:
- Nystatin is NOT recommended for moderate to severe oropharyngeal candidiasis—use oral fluconazole 100-200 mg daily instead 1
- For fluconazole-refractory disease, nystatin is not effective; escalate to itraconazole solution, posaconazole, or other systemic agents 1
Denture-Related Candidiasis
Use the same dosing as above (suspension or pastilles), but denture disinfection is mandatory in addition to antifungal therapy 1. Without addressing the denture, treatment will fail.
Vaginal Candidiasis
For C. glabrata vulvovaginitis (azole-resistant cases):
- Nystatin intravaginal suppositories (dose not specified in guidelines, but typically 100,000 U daily for 14 days based on standard practice) 1
- This is a second-line option when azoles fail
- May combine with boric acid gelatin capsules (600 mg intravaginally daily) for refractory cases 1
Formulation Details
The FDA-approved nystatin oral suspension contains 100,000 units per mL 2:
- Available in cherry or bubblegum flavored formulations
- Unit dose cups deliver 5 mL (500,000 units total) 2
- Bottles available in 60 mL, 237 mL, and 480 mL sizes 2
Critical Dosing Nuances
Higher doses may be more effective: Research suggests that nystatin pastilles at 400,000 U achieve significantly higher mycological cure rates than 200,000 U 3. However, the IDSA guidelines recommend the lower dose, likely balancing efficacy with tolerability.
Combination therapy may be superior: Using nystatin suspension AND pastilles together for 2 weeks appears to achieve higher cure rates than suspension alone 3. Consider this approach for patients failing monotherapy.
Duration matters: Treatment for 4 weeks shows better clinical efficacy than 2 weeks 3, though standard guidelines recommend 7-14 days. Extend duration for persistent cases.
Common Pitfalls
Inadequate contact time: Patients must swish the suspension thoroughly and hold it in the mouth before swallowing. Pastilles must dissolve slowly in the mouth, not be chewed or swallowed whole.
Poor distribution: Nystatin is poorly and unevenly distributed through the GI tract—even at doses up to 12 million units daily, 20-38% of fecal samples contain undetectable nystatin levels 4. This explains treatment failures.
Using nystatin for esophageal candidiasis: This is inappropriate. Esophageal candidiasis requires systemic therapy with fluconazole 200-400 mg daily for 14-21 days 1.
Expecting nystatin to work for moderate-severe disease: Nystatin is only for mild oropharyngeal candidiasis. Fluconazole is superior for anything beyond mild disease 1.
Safety Profile
- Well tolerated: Most common adverse effects are poor taste and mild GI upset 3
- Very safe: Oral doses exceeding 5 million units daily have caused only nausea and GI upset, with no serious toxicity reported 2
- No systemic absorption: Nystatin is not absorbed from the GI tract, making it safe but limiting its utility to mucosal infections 2